Ibrahim Abu-Gheida (@iabugheidamd) 's Twitter Profile
Ibrahim Abu-Gheida

@iabugheidamd

Radiation Oncologist. Proud 🇯🇴 AUB, CCF & MDACC Grad. 🇦🇪-based. tweets=my opinion

ID: 910130024333922304

calendar_today19-09-2017 13:14:41

1,1K Tweet

667 Followers

473 Following

Prof.Dr.Humaid Al-Shamsi 🇦🇪 (@alshamsi2000) 's Twitter Profile Photo

فخور بالكفاءات العربية في علاج السرطان وبخاصة الكفاءات السعودية ، المملكة تمتلك نخبة من أفضل الأطباء في جميع التخصصات وخاصة في مجال السرطان والأورام. أسعد دائما بالتعاون المستمر بين الأشقاء لتطوير وتحسين طرق علاج السرطان في منطقتنا الخليجية والعربية. الصورة على هامش المؤتمر

فخور بالكفاءات العربية في علاج السرطان وبخاصة الكفاءات السعودية ، المملكة تمتلك نخبة من أفضل الأطباء في جميع التخصصات وخاصة في مجال السرطان والأورام. أسعد دائما بالتعاون المستمر بين الأشقاء لتطوير وتحسين طرق علاج السرطان في منطقتنا الخليجية والعربية. الصورة على هامش المؤتمر
Drew Moghanaki 🐕 (@drewmoghanaki) 's Twitter Profile Photo

Upfront radiotherapy for brain metastases was associated with longer overall survival in patients with NSCLC who received ICI alone; however, it did not exhibit survival benefits in the patients who received ICI-chemo. 🇯🇵 #radonc jtocrr.org/article/S2666-…

Upfront radiotherapy for brain metastases was associated with longer overall survival in patients with NSCLC who received ICI alone; however, it did not exhibit survival benefits in the patients who received ICI-chemo. 🇯🇵 #radonc jtocrr.org/article/S2666-…
Ross Harrison, MD MPH (@rossfh) 's Twitter Profile Photo

Adding cisplatin to radiation doesn't improve progression-free survival for localized recurrent #endometrialcancer but does increase treatment-related toxicity. Radiation remains standard of care. ascopubs.org/doi/10.1200/JC… Journal of Clinical Oncology Ann Klopp David Scott Miller #gyncsm #gynonc

Adding cisplatin to radiation doesn't improve progression-free survival for localized recurrent #endometrialcancer but does increase treatment-related toxicity. Radiation remains standard of care. ascopubs.org/doi/10.1200/JC… <a href="/JCO_ASCO/">Journal of Clinical Oncology</a> <a href="/AnnKloppMD/">Ann Klopp</a> <a href="/dsmgyo/">David Scott Miller</a> #gyncsm #gynonc
Denise De la Cruz, Ed.D. (@yogagirldd) 's Twitter Profile Photo

Our 7th Annual Pediatric Radiation Oncology Virtual Course for #RadOnc Residents and Fellows is Friday, May 10th. Chelsea C Pinnix MD PhD Emma B. Holliday MD   Register in advance for this free course: mdacc.zoom.us/meeting/regist…

Our 7th Annual Pediatric Radiation Oncology Virtual Course for #RadOnc Residents and Fellows is Friday, May 10th. <a href="/ChelseaPinnix/">Chelsea C Pinnix MD PhD</a> <a href="/DrEmmaHolliday/">Emma B. Holliday MD</a> 
 
Register in advance for this free course:
mdacc.zoom.us/meeting/regist…
Krishan Jethwa (@krishanjethwa) 's Twitter Profile Photo

🚨🚨RTOG 0848🚨🚨 Anatomically resectable PDAC randomized postoperatively 1st randomization: Gemcitabine +/- erlotinib (no benefit with erlotinib) 🔥2nd Randomization🔥 +/- Chemoradiation, 50.4 Gy/28 fx + cape ✅⬆️ DFS w/ ☢️ ✅N0, ⬆️DFS and OS (5y 48% vs 29%) w/ ☢️ #asco24

🚨🚨RTOG 0848🚨🚨

Anatomically resectable PDAC randomized postoperatively
 1st randomization:

Gemcitabine +/- erlotinib (no benefit with erlotinib)

🔥2nd Randomization🔥
+/- Chemoradiation, 50.4 Gy/28 fx + cape

✅⬆️ DFS w/ ☢️
✅N0, ⬆️DFS and OS (5y 48% vs 29%) w/ ☢️
#asco24
Sana Sukhun - د.سناء السخن (@sanaalsukhun) 's Twitter Profile Photo

Honoured and proud to be decorated by عبدالله بن الحسين “the King Abdullah II Medal for Excellence”, a special #Jordanian royal decoration, awarded to prominent figures with distinguished contributions on #IndependenceDay78 RHC قناة المملكة

Honoured and proud to be decorated by <a href="/KingAbdullahII/">عبدالله بن الحسين</a> “the King Abdullah II Medal for Excellence”, a special #Jordanian royal decoration, awarded to prominent figures with distinguished contributions on #IndependenceDay78 <a href="/RHCJO/">RHC</a> <a href="/AlMamlakaTV/">قناة المملكة</a>
Shankar Siva (@_shankarsiva) 's Twitter Profile Photo

Great discussion of ESOPEC by Dr Karen Goodman; issues raised around low dose of #radiotherapy, lower completion rates than expected, low intensity systemic therapy (high distant failure), lack of CROSS + #immunotherapy. ?Consider CROSS +I/O for less for patients #radonc #ASCO24

Great discussion of ESOPEC by Dr Karen Goodman; issues raised around low dose of #radiotherapy, lower completion rates than expected, low intensity systemic therapy (high distant failure), lack of CROSS + #immunotherapy. ?Consider CROSS +I/O for less for patients #radonc #ASCO24
Shankar Siva (@_shankarsiva) 's Twitter Profile Photo

Dr. David Palma Fiona McDonald Also included induced oligometastases in this study + primary was only treated in <1/3rd. Not all patients had TOTAL METASTATIC ABLATION! Caveat; retrospective data, but treatment of all sites of disease in ‘oligo’ setting we found to be important …. sciencedirect.com/science/articl…

<a href="/drdavidpalma/">Dr. David Palma</a> <a href="/fifimcdrmh/">Fiona McDonald</a> Also included induced oligometastases in this study + primary was only treated in &lt;1/3rd. Not all patients had TOTAL METASTATIC ABLATION! Caveat; retrospective data, but treatment of all sites of disease in ‘oligo’ setting we found to be important …. sciencedirect.com/science/articl…
Drew Moghanaki 🐕 (@drewmoghanaki) 's Twitter Profile Photo

Radiation oncologists making time to keep up with what's happening at #ASCO24 might enjoy reading this perspective by the illustrious Ben Corn and the late Eli Glatstein. #radonc sciencedirect.com/science/articl…

Radiation oncologists making time to keep up with what's happening at #ASCO24 might enjoy reading this perspective by the illustrious Ben Corn and the late Eli Glatstein. #radonc sciencedirect.com/science/articl…
Krishan Jethwa (@krishanjethwa) 's Twitter Profile Photo

🔥TNTCRT Trial 🔵ph3 RCT, N=458, mFU 44m 🔎High risk stage 2-3 rectal cancer : cT4a-b, cT3c-d w/ EMVI, cN2; +MRF, +LPLNs LC-CRT + Cape ➡️🔪➡️CAPOX vs TNT: 6c CAPOX + LC-CRT➡️🔪 🔑TNT Improved: ✅DFS3: 77% vs 68% ✅MFS3: 83% vs 74% ✅pCR: 28% vs 10% 🔵OS3 90% vs 88% #ASCO24

🔥TNTCRT Trial

🔵ph3 RCT, N=458, mFU 44m
🔎High risk stage 2-3 rectal cancer : cT4a-b, cT3c-d w/ EMVI, cN2; +MRF, +LPLNs

LC-CRT + Cape ➡️🔪➡️CAPOX
vs
TNT: 6c CAPOX + LC-CRT➡️🔪

🔑TNT Improved:
✅DFS3: 77% vs 68%
✅MFS3: 83% vs 74%
✅pCR: 28% vs 10%
🔵OS3 90% vs 88%
#ASCO24
C. Jillian Tsai, MD, PhD (@cjtsaimdphd) 's Twitter Profile Photo

🚨📢Happening now - HN oral abstracts #ASCO24‼️ PRACTICE CHANGING trial of hypoxia directed major radiation de-escalation as definitive treatment for HPV+OPC by Nancy Lee Memorial Sloan Kettering Radiation Oncology Memorial Sloan Kettering Cancer Center, showing that 30Gy+Chemo is sufficient for cure, with > 500 pts treated so far.

🚨📢Happening now - HN oral abstracts #ASCO24‼️

PRACTICE CHANGING trial of hypoxia directed major radiation de-escalation as definitive treatment for HPV+OPC by <a href="/imrtlee/">Nancy Lee</a> <a href="/MSK_RadOnc/">Memorial Sloan Kettering Radiation Oncology</a> <a href="/MSKCancerCenter/">Memorial Sloan Kettering Cancer Center</a>, showing that 30Gy+Chemo is sufficient for cure, with &gt; 500 pts treated so far.
Matthias Guckenberger (@mat_guc) 's Twitter Profile Photo

RT and SBRT are highly effective for localized prostate cancer Nevertheless, there are few pts with intraprostatic failure Prospective study of salvage reirradiation ascopubs.org/doi/10.1200/JC… 5-year local recurrence-free survival: 93% Durable grade 3 genitourinary toxicity: 5%

Rahul Tendulkar, MD (@rtendulkarmd) 's Twitter Profile Photo

Burnout & moral injury in medicine have affected so many health care workers. As a mid-career physician, here’s what I’ve learned to combat it - I hope others find it to be helpful. In Search of Joy and Meaning in Modern Medicine JCO Oncology Practice ascopubs.org/doi/pdf/10.120…

Burnout &amp; moral injury in medicine have affected so many health care workers. As a mid-career physician, here’s what I’ve learned to combat it - I hope others find it to be helpful.
In Search of Joy and Meaning in Modern Medicine <a href="/JCOOP_ASCO/">JCO Oncology Practice</a> ascopubs.org/doi/pdf/10.120…
John Suh (@drjohnsuh) 's Twitter Profile Photo

Outstanding thoughts by Rahul Tendulkar, MD on his search of joy and meaning in modern medicine! 👏His #leadership and emotional intelligence have allowed us to have a special #radonc residency program and have allowed us to hire & retain some of our best graduates. #CleClinicCancer

Joe Y Chang (@joechangmd) 's Twitter Profile Photo

Positive or negative? The devil is in the details. Pt select, EGFR/ALK status (Asian), SABR BED/delivery, timing/sequence change biology of RT/IO interactions. Not all RT is created equal. Issue becomes more complicated when IO involved. AI-guided personalized approach needed.

Positive or negative?

The devil is in the details. Pt select, EGFR/ALK status (Asian), SABR BED/delivery, timing/sequence change biology of RT/IO interactions. 
Not all RT is created equal. Issue becomes more complicated when IO involved. 
AI-guided personalized approach needed.
Ibrahim Abu-Gheida (@iabugheidamd) 's Twitter Profile Photo

#grateful be part of this #group #collaborative effort highlighting the value of #peerreview in the field of #Oncology in general and #Radiation in specific. Kudos to Dr Issa from مؤسسة ومركز الحسين للسرطان & the entire team BMC | Burjeel Medical City دائرة الصحة - أبوظبي FANR UAE 🇦🇪 ascopubs.org/doi/10.1200/GO…

#grateful be part of this #group #collaborative effort highlighting the value of #peerreview in the field of #Oncology in general and #Radiation in specific. Kudos to Dr Issa from <a href="/KHCFKHCC/">مؤسسة ومركز الحسين للسرطان</a>  &amp; the entire team
<a href="/BurjeelMediCity/">BMC | Burjeel Medical City</a> <a href="/DoHSocial/">دائرة الصحة - أبوظبي</a> <a href="/FANRUAE/">FANR UAE</a> 🇦🇪 
ascopubs.org/doi/10.1200/GO…